Clinical Trial Update: Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an immunomodulatory therapy for psychiatric disorders with proven dysimmunity; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mental Disorder

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Mental Disorder | Phase 3 | Status: NOT_YET_RECRUITING